Hjem › Bugspytkirtelkræft › Oklahoma
Bugspytkirtelkræft kliniske forsøg i Oklahoma
12 studier for Bugspytkirtelkræft søger deltagere på steder i Oklahoma.
Byer i Oklahoma
Officiel studietekst (engelsk)
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- University of Oklahoma, Oklahoma City
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06128551A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Mercy Hospital Oklahoma City - Mercy Coletta Cancer Center - Oklahoma City, Oklahoma City
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07409272Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Stephenson Cancer Center, Oklahoma City
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06445062Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- University of Oklahoma Health Sciences Center, Oklahoma City
RekruttererObservationsstudie
Alder 50 til 75 · Alle køn · Opdateret 4. sep. 2026 · NCT04239573The Vanguard Study: Testing a New Way to Screen for Cancer
- University of Oklahoma Health Sciences Center, Oklahoma City
RekruttererFrivillige med god helbredstilstand velkomne
Alder 45 til 75 · Alle køn · Opdateret 2. sep. 2026 · NCT06995898A Study of DM002 in Patients With Advanced Solid Tumors
- University of Oklahoma Health Sciences Center, Oklahoma City
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 7. aug. 2026 · NCT06751329Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
- University of Oklahoma Health Sciences Center, Oklahoma City
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 15. jul. 2026 · NCT05053971Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
- Hightower Clinical, Oklahoma City
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. jul. 2026 · NCT06937177ctDNA Assay in Patients With Resectable Pancreatic Cancer
- University of Oklahoma, Oklahoma City
- Stephenson Cancer Center- Tulsa, Tulsa
RekruttererObservationsstudie
Alder 18 til 99 · Alle køn · Opdateret 5. mar. 2026 · NCT05052671A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Oklahoma City
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 17. feb. 2026 · NCT06906562SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Tulsa
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
- Exelixis Clinical Site #13, Oklahoma City
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 5. sep. 2025 · NCT05932862Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.